November 28 (SeeNews) - Bulgarian veterinary drug maker Biovet [BUL:53B] said on Monday its consolidated net profit rose to 11.9 million levs ($6.4 million/6.1 million euro) in the first nine months of 2016, from 6.3 million levs in the corresponding period of last year.
about 12 hours agoabout 15 hours agoabout 18 hours ago
about 12 hours agoabout 15 hours agoabout 18 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
